{
    "match": true,
    "technologies": [
        {
            "name": "Biotechnology (focused on molecules and cells)",
            "priority": 1,
            "evidence": "Aglaia invests in oncology drug development companies. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment."
        },
        {
            "name": "Artificial Intelligence (AI) and Data",
            "priority": 2,
            "evidence": "The joint development of a fully dedicated, highly versatile and flexible web-based platform for impact measuring and reporting in the life sciences industry, called Life Sciences Impact Suite."
        }
    ],
    "reason_no_match": null
}